论文部分内容阅读
目的探讨剖宫产术后子宫瘢痕处妊娠的临床表现及治疗效果。方法 62例剖宫产术后子宫瘢痕处妊娠孕妇,将其随机分为对照组和治疗组,各31例。对照组采用药物保守治疗,治疗组在甲氨蝶呤(MTX)肌内注射+宫腔内注射联合超声引导下实施清宫治疗。对比分析两组的治疗效果、瘢痕部位包块消失时间、平均住院时间等。结果治疗组总有效率高于对照组,差异有统计学意义(P<0.05)。治疗组瘢痕部位包块消失时间、平均住院时间短于对照组,差异有统计学意义(P<0.05)。结论在MTX肌内注射+宫腔内注射联合超声引导下对剖宫产术后子宫瘢痕处妊娠孕妇实施清宫治疗,安全性高,治疗效果剂量,值得临床推广应用。
Objective To investigate the clinical manifestations and treatment of uterine scar pregnancy after cesarean section. Methods Sixty-two pregnant women with uterine scar after cesarean section were randomly divided into control group and treatment group, with 31 cases in each group. The control group was treated with conservative drugs. The treatment group was treated with methotrexate (MTX) intramuscular injection and intrauterine injection combined with ultrasound guided cure. Comparative analysis of the two groups of treatment, scar site mass disappearance of time, the average length of stay and so on. Results The total effective rate of the treatment group was higher than that of the control group, with significant difference (P <0.05). The disappearance time of the mass in the scar site and the average length of stay in the treatment group were significantly shorter than those in the control group (P <0.05). Conclusions Under MTX intramuscular injection combined with intrauterine injection combined with ultrasound guided cesarean section uterine scar pregnant women in the implementation of curettage, high safety, therapeutic effect dose, worthy of clinical application.